last data update: 2011/10/14, 06:20

Website loading time

during the test: 2.41 s

cable connection (average): 2.63 s

DSL connection (average): 2.84 s

modem (average): 14.31 s

HTTP headers

Information about DNS servers

gekkowire.comSOAns1.dreamhost.comhostmaster.dreamhost.com201102090216881 1800 1814400 14400 IN 14400
gekkowire.comMX0mx1.sub3.homie.mail.dreamhost.comIN14400
gekkowire.comMX0mx2.sub3.homie.mail.dreamhost.comIN14400
gekkowire.comA69.163.150.255IN14400
gekkowire.comNSns1.dreamhost.comIN14400
gekkowire.comNSns2.dreamhost.comIN14400
gekkowire.comNSns3.dreamhost.comIN14400

Received from the first DNS server

Request to the server "gekkowire.com"
You used the following DNS server:
DNS Name: ns1.dreamhost.com
DNS Server Address: 66.33.206.206#53
DNS server aliases:

HEADER opcode: REQUEST, status: NOERROR, id: 17912
flag: qr aa rd REQUEST: 1, ANSWER: 7, AUTHORITY: 0, ADDITIONAL: 5

REQUEST SECTION:
gekkowire.com. IN ANY

ANSWER SECTION:
gekkowire.com. 14400 IN MX 0 mx1.sub3.homie.mail.dreamhost.com.
gekkowire.com. 14400 IN SOA ns1.dreamhost.com. hostmaster.dreamhost.com. 2011020902 16881 1800 1814400 14400
gekkowire.com. 14400 IN NS ns1.dreamhost.com.
gekkowire.com. 14400 IN NS ns2.dreamhost.com.
gekkowire.com. 14400 IN MX 0 mx2.sub3.homie.mail.dreamhost.com.
gekkowire.com. 14400 IN A 69.163.150.255
gekkowire.com. 14400 IN NS ns3.dreamhost.com.

SECTION NOTES:
ns3.dreamhost.com. 14400 IN A 66.33.216.216
mx1.sub3.homie.mail.dreamhost.com. 14400 IN A 208.97.132.221
ns1.dreamhost.com. 14400 IN A 66.33.206.206
ns2.dreamhost.com. 14400 IN A 208.96.10.221
mx2.sub3.homie.mail.dreamhost.com. 14400 IN A 208.97.132.222

Received 294 bytes from address 66.33.206.206#53 in 76 ms

Received from the second DNS server

Request to the server "gekkowire.com"
You used the following DNS server:
DNS Name: ns2.dreamhost.com
DNS Server Address: 208.96.10.221#53
DNS server aliases:

HEADER opcode: REQUEST, status: NOERROR, id: 14103
flag: qr aa rd REQUEST: 1, ANSWER: 7, AUTHORITY: 0, ADDITIONAL: 5

REQUEST SECTION:
gekkowire.com. IN ANY

ANSWER SECTION:
gekkowire.com. 14400 IN NS ns2.dreamhost.com.
gekkowire.com. 14400 IN NS ns1.dreamhost.com.
gekkowire.com. 14400 IN A 69.163.150.255
gekkowire.com. 14400 IN MX 0 mx1.sub3.homie.mail.dreamhost.com.
gekkowire.com. 14400 IN MX 0 mx2.sub3.homie.mail.dreamhost.com.
gekkowire.com. 14400 IN SOA ns1.dreamhost.com. hostmaster.dreamhost.com. 2011020902 16881 1800 1814400 14400
gekkowire.com. 14400 IN NS ns3.dreamhost.com.

SECTION NOTES:
ns1.dreamhost.com. 14400 IN A 66.33.206.206
mx2.sub3.homie.mail.dreamhost.com. 14400 IN A 208.97.132.222
mx1.sub3.homie.mail.dreamhost.com. 14400 IN A 208.97.132.221
ns3.dreamhost.com. 14400 IN A 66.33.216.216
ns2.dreamhost.com. 14400 IN A 208.96.10.221

Received 294 bytes from address 208.96.10.221#53 in 83 ms

Subdomains (the first 50)

Typos (misspells)

fekkowire.com
vekkowire.com
bekkowire.com
hekkowire.com
yekkowire.com
tekkowire.com
gwkkowire.com
gskkowire.com
gdkkowire.com
grkkowire.com
g4kkowire.com
g3kkowire.com
gejkowire.com
gemkowire.com
gelkowire.com
geokowire.com
geikowire.com
gekjowire.com
gekmowire.com
geklowire.com
gekoowire.com
gekiowire.com
gekkiwire.com
gekkkwire.com
gekklwire.com
gekkpwire.com
gekk0wire.com
gekk9wire.com
gekkoqire.com
gekkoaire.com
gekkosire.com
gekkoeire.com
gekko3ire.com
gekko2ire.com
gekkowure.com
gekkowjre.com
gekkowkre.com
gekkowore.com
gekkow9re.com
gekkow8re.com
gekkowiee.com
gekkowide.com
gekkowife.com
gekkowite.com
gekkowi5e.com
gekkowi4e.com
gekkowirw.com
gekkowirs.com
gekkowird.com
gekkowirr.com
gekkowir4.com
gekkowir3.com
ekkowire.com
gkkowire.com
gekowire.com
gekowire.com
gekkwire.com
gekkoire.com
gekkowre.com
gekkowie.com
gekkowir.com
egkkowire.com
gkekowire.com
gekkowire.com
gekokwire.com
gekkwoire.com
gekkoiwre.com
gekkowrie.com
gekkowier.com
ggekkowire.com
geekkowire.com
gekkkowire.com
gekkkowire.com
gekkoowire.com
gekkowwire.com
gekkowiire.com
gekkowirre.com
gekkowiree.com

Location

IP: 69.163.150.255

continent: NA, country: United States (USA), city: Brea

Website value

rank in the traffic statistics: 1 620 257

There is not enough data to estimate website value.

Basic information

website build using CSS

code weight: 83.28 KB

text per all code ratio: 17 %

title: GekkoWire

description:

keywords: fda calendar, pharmaceutical, pharmaceuticals, biotech investing, clinical trial data, clinical trials, small pharma blog, biotech calendar, biotechnology calendar, fda approval dates, fda approval, phase III, phase 3, phase II, phase 2, gekko, gekkowrie, gekkowire, gekkowrie, geckowire, geccowire, food and drug, fda, adam feuerstein, adam feurstein, adamf, genta, genasense, ampligen, nimotuzumab, nimo, YM biosciences, HemispherX, Biomoda, Cypath, cell therapeutics, opaxio, pixantrone, PGT307, AGENDA trial, CLL, EXTEND trial, Avanir, Zenvia, MS, ALS, Generex, Oral-Lyn, CombinatoRX, Exalgo, pain medication, opioid, EMBEDA, back pain, EMBBEDDA, Myriad

encoding: UTF-8

language: en-US

Website code analysis

one word phrases repeated minimum three times

two word phrases repeated minimum three times

three word phrases repeated minimum three times

B tags

U tags

I tags

images

file namealternative text
Google
Loading ...
spinner
iCalendar
Cordobo Green Park 2 logo

headers

H1

GekkoWire

Depomed (DEPO): Serada Breeze 3 Results Miss Endpoints

Daily Pharma Watch

Gentium (GENT) After Pulling Their NDA

Transcept (TSPT): Intermezzo Gets Win With Class 1 Filing, Analysis (Trading tips included)

Neoprobe (NEOP): My Opinion on the Matter of an RTF

Catalyst Corner

BioDelivery Sciences (BDSI): Misses Primary Endpoint In Pain Study

Biodel (BIOD): Discontinues Phase 1 Drugs BIOD 105 and BIOD 107, Path Forward (Risk Analysis)

Mela Sciences (MELA) Receives FDA Approvable Letter

H2

H3

H4

H5

H6

internal links

addressanchor text
Home
Content
RSS
Log in
GekkoWire
Home
About
Contact/Email/Request
My Drug Analysis Articles
Store
Today’s Pharma PR
Depomed (DEPO): Serada Breeze 3 Results Miss Endpoints
No comments
Uncategorized
DEPO
Daily Pharma Watch
No comments
Uncategorized
ANDS
cycc
ISTA
KV.A
MITI
PIP
POZN
TELK
Gentium (GENT) After Pulling Their NDA
1 comment
Uncategorized
Daily Pharma Watch
No comments
Uncategorized
ALTH
AMAG
ONXX
RNN
Daily Pharma Watch
2 comments
Uncategorized
BPAX
DEPO
dvax
IMMU
INSM
ISIS
Kerx
TRGT
Transcept (TSPT): Intermezzo Gets Win With Class 1 Filing, Analysis (Trading tips included)
6 comments
Uncategorized
TSPT
Daily Pharma Watch
3 comments
Uncategorized
AIS
cvm
POZN
SCLN
TSPT
Neoprobe (NEOP): My Opinion on the Matter of an RTF
32 comments
Uncategorized
NEOP
Daily Pharma Watch
No comments
Uncategorized
anx
NVAX
SMO
XOMA
Catalyst Corner
8 comments
Uncategorized
ALIM
ALXA
ANDS
anx
ARQL
BIOD
CHTP
DSCO
HZNP
Kerx
MDVN
NEOP
NPSP
ONXX
PATH
PCRX
PCYC
PSDV
PTIE
RNN
TLON
TSPT
YMI
Daily Pharma Watch
No comments
Uncategorized
TSRX
BioDelivery Sciences (BDSI): Misses Primary Endpoint In Pain Study
1 comment
Uncategorized
BDSI
Daily Pharma Watch
No comments
Uncategorized
ACTC
AEGR
CHTP
HZNP
ONXX
RNN
TSPT
YMI
Biodel (BIOD): Discontinues Phase 1 Drugs BIOD 105 and BIOD 107, Path Forward (Risk Analysis)
10 comments
Uncategorized
BIOD
Mela Sciences (MELA) Receives FDA Approvable Letter
4 comments
Uncategorized
MELA
View Results
Avanir Pharmaceuticals (AVNR): Bulls And Bears
Arena Pharmaceuticals (ARNA) Briefing Document Prep: Bulls and Bears
Arena Lorcaserin Briefing Document Approval Analysis (Update Complete)
Avanir Pharmaceuticals (AVNR) Approval Estimate
Mannkind (MNKD) Bulls and Bears
Delcath Systems (DCTH) Share Price Target
Mannkind (MNKD): Approval Odds (My Opinion)
Mannkind (MNKD): Data Review, Including 014 Data and the Works!
Jan
October 2011
28
November 2011
12
14
December 2011
8
About
Contact/Email/Request
My Drug Analysis Articles
Store
Today’s Pharma PR
October 2011
September 2011
August 2011
July 2011
June 2011
May 2011
April 2011
March 2011
February 2011
January 2011
December 2010
November 2010
October 2010
September 2010
August 2010
July 2010
June 2010
May 2010
April 2010
March 2010
February 2010
January 2010
December 2009
November 2009
October 2009
September 2009
August 2009
Achillion
ACH-1625
Acra
Acura
Advaxis
AEterna Zentaris
Antigenics
Arena
Ariad
ArQule Inc
Avanir
Zenvia
Biomoda
Cell Therapeutics
Opaxio
Pixantrone
Celldex
CombinatoRX
Exalgo
cyclacel
Delcath
Dendreon
Dr. Pazdur
FDA/Events
Genasense
Generex
AE37
Oral-Lyn
Genta
8.26.09 Conference Call Transcript
GenVec
Geron
Hana Biosciences
HemispherX
Ampligen
Human Genome Sciences
Immunocellular Therapeutics
intermune
Keryx
Perifosine
Labopharm
Lifeline Biotech
mannkind
Nektar
Novelos
Power 3
Pozen
Rexahn
Sunesis
Voreloxin
Uncategorized
Vivus
Qnexa
YM Biosciences
ZIOPHARM Oncology
img
img
img
Back to Top

external links

addressanchor text
We respect your email privacy
EC
EC
BioRunUp
Biotechduediligence
Chasingthealpha
Green Stocks
Tro Kalayjian
Twitter
Get this plugin for my blog
grab this
grab this
img
grab this
WordPress
Green Park 2
Cordobo